Home/Filings/4/0001104659-18-014879
4//SEC Filing

Engelking Dorothy 4

Accession 0001104659-18-014879

CIK 0001467652other

Filed

Mar 4, 7:00 PM ET

Accepted

Mar 5, 5:16 PM ET

Size

7.0 KB

Accession

0001104659-18-014879

Insider Transaction Report

Form 4
Period: 2018-03-01
Engelking Dorothy
VP, Regulatory Affairs
Transactions
  • Award

    Common Stock

    2018-03-01+3,75010,416 total
  • Award

    Stock Option (Right to Buy)

    2018-03-01+11,25011,250 total
    Exercise: $8.30Exp: 2028-03-01Common Stock (11,250 underlying)
Footnotes (2)
  • [F1]Represents shares of common stock underlying restricted stock unit grants awarded to the Reporting Person. The restricted stock units will vest in four equal, annual installments beginning on March 1, 2019.
  • [F2]This stock option will vest in four equal, annual installments beginning on March 1, 2019.

Documents

1 file

Issuer

Neos Therapeutics, Inc.

CIK 0001467652

Entity typeother

Related Parties

1
  • filerCIK 0001647582

Filing Metadata

Form type
4
Filed
Mar 4, 7:00 PM ET
Accepted
Mar 5, 5:16 PM ET
Size
7.0 KB